Victory Capital Management Inc. lessened its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 1.9% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 75,688 shares of the company’s stock after selling 1,497 shares during the quarter. Victory Capital Management Inc.’s holdings in Avanos Medical were worth $1,819,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the business. Tidal Investments LLC acquired a new position in shares of Avanos Medical in the 1st quarter valued at $439,000. Boston Partners purchased a new position in Avanos Medical during the first quarter worth about $571,000. Quest Partners LLC acquired a new stake in shares of Avanos Medical during the second quarter valued at about $444,000. Deerfield Management Company L.P. Series C acquired a new stake in shares of Avanos Medical during the second quarter valued at about $551,000. Finally, AQR Capital Management LLC raised its stake in shares of Avanos Medical by 21.0% in the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock valued at $2,875,000 after acquiring an additional 25,467 shares during the period. 95.17% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.
Avanos Medical Stock Performance
Shares of Avanos Medical stock opened at $18.60 on Monday. The stock has a market capitalization of $854.86 million, a price-to-earnings ratio of 54.71 and a beta of 0.92. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The business has a 50-day moving average of $21.73 and a 200 day moving average of $21.54. Avanos Medical, Inc. has a 12 month low of $17.39 and a 12 month high of $25.36.
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
- Five stocks we like better than Avanos Medical
- 3 Healthcare Dividend Stocks to Buy
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Ride Out The Recession With These Dividend Kings
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Stock Analyst Ratings and Canadian Analyst Ratings
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.